Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
์ข
๋ชฉ ์ฝ๋ PFE
ํ์ฌ ์ด๋ฆPfizer Inc
์์ฅ์ผFeb 22, 2080
CEOBourla (Albert)
์ง์ ์81000
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃFeb 22
์ฃผ์66 Hudson Boulevard East
๋์NEW YORK
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX NASDAQ Basic NYSE
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ10001-2192
์ ํ12127332323
์น์ฌ์ดํธhttps://www.pfizer.com/
์ข
๋ชฉ ์ฝ๋ PFE
์์ฅ์ผFeb 22, 2080
CEOBourla (Albert)